RxDoctor Payments Data

Jenna Davison

Physician Assistant · Ft Worth, TXNPI 1417293960

Payments from drug & device makers

$11,732in general payments, 2019–2025

Across 572 payments — averaging $20.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$1K
  • AstraZeneca$843
  • Sanofi-aventis U.S. LLC$801
  • Novo Nordisk$796
  • Amgen$745
  • Boehringer Ingelheim$654
  • plus $7K from 52 others
$126in research payments, 2019–2025

Across 1 payment — averaging $126.02 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Corcept Therapeutics$126

What the payments were for

  • Food & beverage$11,695100%
  • Education$370%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$11,732 in reported general payments places this provider in the 95th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide49$87,666
MounjaroTirzepatide43$74,544
JardianceEmpagliflozin58$61,828
TrulicityDulaglutide41$46,972
Tresiba Flextouch U-100Insulin Degludec42$38,797
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/723$32,749
Omnipod Dash Pods (Gen 4)Insulin Pump Cart,cont Inf,bt23$19,941
JanuviaSitagliptin Phosphate29$19,218
SynthroidLevothyroxine Sodium217$17,801
FarxigaDapagliflozin Propanediol11$15,691
Humalog Kwikpen U-100Insulin Lispro32$12,510
Novolog FlexpenInsulin Aspart27$10,558
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog16$8,763
Lantus SolostarInsulin Glargine,hum.Rec.Anlog56$8,447
NovologInsulin Aspart14$8,402

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity, Humalog$1,010$128,49196 claims
Novo NordiskOzempic, Novolog$796$96,06763 claims
Boehringer IngelheimJardiance$654$61,82858 claims
MerckJanuvia$56$19,21829 claims
AbbVieSynthroid$407$17,801217 claims
AstraZenecaFarxiga$843$15,69111 claims
IBSA Pharma Inc.Tirosint$53$4,18926 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid$181$2,542234 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Ft Worth

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →